Maryam Tabatabai, PharmD, vice president of clinical information, and Carole Kerzic, RPh, drug information pharmacist, share more about glucagon-like peptide-1 (GLP-1) receptor agonists in the drug...

New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more

In the latest episode of the “Pharmacy Friends” podcast, join health outcomes experts for a discussion about Prime’s industry-leading research into persistence and adherence of glucagon-like...

Novo Nordisk’s semaglutide (Wegovy) recently received a U.S. Food and Drug Administration (FDA) accelerated approval for treating metabolic dysfunction-associated steatohepatitis (MASH), the first...

New resource page offers the latest GLP-1 insights, research and perspectives

New report details the latest on GLP-1s

Following real-world analysis of GLP-1 drugs for weight loss, Prime/Magellan Rx releases new video about GLP-1 research

Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

In this second of a two-part episode of the Pharmacy Friends podcast, industry experts discuss clinical evidence, drug information and appropriate patient selection for GLP-1 use

What to expect at Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Live updates from AMCP Annual Meeting

The event emphasizes additional measures for obesity therapy.

Prime Therapeutics researchers share more about award-winning real-world research

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

In the latest episode of the “Pharmacy Friends” podcast, hear about a new clinical report from Prime Therapeutics that dives into the latest evidence-based insights related to the rising prevalence...

Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

Academy of Managed Care Pharmacy (AMCP)'s Annual Meeting gathers thousands of health plan, pharmacy benefit management and biopharmaceutical experts to help define the future of managed care pharmacy.

From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights

Prime’s industry-leading research on GLP-1s was recognized at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting in Houston

Prime Therapeutics Report shares more about single-treatment gene therapies and proper management

New report explores traditional, specialty therapy trend impact to employers

From next-gen CFTR modulators to gene therapy and real-world drug impact, cystic fibrosis care is constantly evolving. Maryam Tabatabai, PharmD, of Prime Therapeutics, explains how innovative...

Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event

A roundup of Prime's award-winning presentations and insights at AMCP Annual Meeting in Houston

In the latest episode of the “Pharmacy Friends” podcast, join Prime’s research team for a preview of the industry-leading and award-winning research that will be presented at flagship industry event

Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costs

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in National Harbor, Maryland

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans

Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in Las Vegas.

More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

Event features discussions about health care industry trends, best practices and innovations

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

In this special episode of the Pharmacy Friends podcast, “Live at Specialty Summit ’24 – Connect. Elevate. Transform.,” we are on the road in New York City at our 21st annual Specialty Summit. More...

Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection

Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point

If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...

Constant communication across the supply chain limits disruption when a drug is unavailable

Recent webinar featuring Prime Therapeutics experts shares some of the latest breakthrough therapies — including ADCs, BiTes and CAR-T treatments — and regulatory changes and market shifts that are...

Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

As the efficacy and cost of these therapies become clear, so is the need for thoughtful managed care strategies, according to Prime Therapeutics thought leaders

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Pharmacy Friends In the latest episode of the “Pharmacy Friends” podcast, learn the latest insights on legislative trends, cutting-edge drug therapies and more from the 22nd annual event Alex Cook...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

image from Healthcare Advocate Summit Prerak Parikh represented Prime on a panel at Healthcare Advocate Summit 2025 in Las Vegas on Sept. 4 with other payer/PBM professionals Prime Therapeutics At...

Annual conference features presentations, panels, discussions and networking

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

cover image for MPTR blog Prime expert shares exciting enhancement to Medical Pharmacy Trend Report Lisa Polakowski Lisa Polakowski, PharmD, is the Medical Pharmacy Trend Report director for Prime...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

Learn how Prime champions cancer care through its industry-leading solutions, clinical insights, charitable giving and volunteer efforts

Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care

Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event

Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality

Recognition benchmarks disability workplace inclusion against other companies